In addition, inhibition of CKMT1 reduces the viability of human EVI1-positive acute myeloid leukemia (AML) cell lines, and promotes cell cycle arrest and apoptosis [16]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.